259 related articles for article (PubMed ID: 11475398)
21. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model.
Bakri SJ; Cameron JD; McCannel CA; Pulido JS; Marler RJ
Am J Ophthalmol; 2006 Jul; 142(1):162-4. PubMed ID: 16815270
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy.
Rodrigues EB; Meyer CH; Mennel S; Farah ME
Retina; 2007 Sep; 27(7):958-70. PubMed ID: 17891024
[TBL] [Abstract][Full Text] [Related]
23. Toxicity study of erucylphosphocholine in a rat model.
Schuettauf F; Eibl KH; Thaler S; Shinoda K; Rejdak R; May CA; Blatsios G; Welge-Lussen U
Curr Eye Res; 2005 Sep; 30(9):813-20. PubMed ID: 16146926
[TBL] [Abstract][Full Text] [Related]
24. Retinal toxicity of indocyanine green in albino rabbits.
Goldstein M; Zemel E; Loewenstein A; Perlman I
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2100-7. PubMed ID: 16639021
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit.
Kozak I; Cheng L; Mendez T; Davidson MC; Freeman WR
Retina; 2006 Sep; 26(7):811-7. PubMed ID: 16963856
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal recombinant human erythropoietin: a safety study in rabbits.
Song BJ; Cai H; Tsai JC; Chang S; Forbes M; Del Priore LV
Curr Eye Res; 2008 Sep; 33(9):750-60. PubMed ID: 18798078
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal toxicity of high-dose etanercept.
Kivilcim M; Peyman GA; Kazi AA; Dellacroce J; Ghobrial RN; Monzano R
J Ocul Pharmacol Ther; 2007 Feb; 23(1):57-62. PubMed ID: 17341152
[TBL] [Abstract][Full Text] [Related]
29. Effects of vancomycin and ofloxacin on rabbit ERG in vivo.
Mochizuki K; Torisaki M; Wakabayashi K
Jpn J Ophthalmol; 1991; 35(4):435-45. PubMed ID: 1821433
[TBL] [Abstract][Full Text] [Related]
30. Effects of intravitreal dispase on vitreoretinal interface in rabbits.
Zhu D; Chen H; Xu X
Curr Eye Res; 2006 Nov; 31(11):935-46. PubMed ID: 17114119
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal toxicity of levofloxacin and gatifloxacin.
Kazi AA; Jermak CM; Peyman GA; Aydin E; Riazi-Esfahani M
Ophthalmic Surg Lasers Imaging; 2006; 37(3):224-9. PubMed ID: 16749259
[TBL] [Abstract][Full Text] [Related]
32. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
Yi NY; Davis JL; Salmon JH; Gilger BC
Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265
[TBL] [Abstract][Full Text] [Related]
33. Determination of nontoxic concentrations of piperacillin/tazobactam for intravitreal application. An electroretinographic, histopathologic and morphometric analysis.
Ozkiriş A; Evereklioglu C; Kontaş O; Oner AO; Erkiliç K
Ophthalmic Res; 2004; 36(3):139-44. PubMed ID: 15103204
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
Taber SW; Fingar VH; Coots CT; Wieman TJ
Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal injection of triamcinolone acetonide into healthy rabbit eyes alters retinal function and morphology.
Myers AC; Bruun A; Ghosh F; Adrian ML; Andréasson S; Ponjavic V
Curr Eye Res; 2013 Jun; 38(6):649-61. PubMed ID: 23537282
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
37. Retinal toxicity of intravitreally injected faeriefungin.
Dunlap WA; Karaçorlu M; Peyman GA; Nair MG; Rahimy M; Pedroza L
Ophthalmic Surg; 1994 May; 25(5):303-6. PubMed ID: 8058262
[TBL] [Abstract][Full Text] [Related]
38. Experimental intravitreal application of trovafloxacin in rabbits.
Gürler B; Ozkul Y; Bitiren M; Satici A; Oguz H; Karadede S
Ophthalmic Res; 2001; 33(4):228-36. PubMed ID: 11464076
[TBL] [Abstract][Full Text] [Related]
39. Effects of kallidinogenase on ischemic changes induced by repeated intravitreal injections of endothelin-1 in rabbit retina.
Nagano H; Wei PZ; Wen CQ; Jomori T; Oku H; Ikeda T; Saito Y; Tano Y
Curr Eye Res; 2007 Feb; 32(2):113-22. PubMed ID: 17364744
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal injection of piperacillin.
Semple HC; Liu JC; Peyman GA
Ophthalmic Surg; 1989 Aug; 20(8):588-90. PubMed ID: 2779969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
